We are live on ! Find out more
SPA

Sherbrooke Park Advisers Portfolio holdings

AUM $38.7M
1-Year Est. Return 5.29%
This Fund
S&P 500
This Quarter Est. Return
+1.77%
1 Year Est. Return
-5.29%
3 Year Est. Return
-9.59%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$301M
Cap. Flow
+$293M
Cap. Flow %
57.02%
Top 10 Hldgs %
5.45%
Holding
1,025
New
585
Increased
167
Reduced
66
Closed
207

Top Buys

Rank Stock Value
1
SSRM icon
SSR Mining
SSRM
+$4.08M
2
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$3.92M
3
SMAR
Smartsheet Inc.
SMAR
+$2.98M
4
LEN icon
Lennar Class A
LEN
+$2.74M
5
DOW icon
Dow Inc
DOW
+$2.55M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$2.12M
2
HOLX
Hologic
HOLX
+$2.01M
3
MPC icon
Marathon Petroleum
MPC
+$1.66M
4
KO icon
Coca-Cola
KO
+$1.58M
5
JBL icon
Jabil
JBL
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 22.07%
2 Industrials 18.09%
3 Consumer Discretionary 13.93%
4 Healthcare 10.29%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NRDY icon
951
Nerdy
NRDY
$94.1M
– –
-15,618
Closed -$53.6K
NWL icon
952
Newell Brands
NWL
$2.5B
– –
-69,235
Closed -$601K
OCUL icon
953
Ocular Therapeutix
OCUL
$2.02B
– –
-19,058
Closed -$85K
OM icon
954
Outset Medical
OM
$96.8M
– –
-934
Closed -$75.8K
OPEN icon
955
Opendoor
OPEN
$3.44B
– –
-47,979
Closed -$208K
ORCL icon
956
Oracle
ORCL
$429B
– –
-5,289
Closed -$558K
ORGO icon
957
Organogenesis Holdings
ORGO
$246M
– –
-46,238
Closed -$189K
ORLY icon
958
O'Reilly Automotive
ORLY
$75.6B
– –
-13,500
Closed -$855K
PAHC icon
959
Phibro Animal Health
PAHC
$1.38B
– –
-12,055
Closed -$140K
PB icon
960
Prosperity Bancshares
PB
$8.85B
– –
-5,664
Closed -$384K
PBI icon
961
Pitney Bowes
PBI
$2.36B
– –
-21,805
Closed -$95.9K
PCAR icon
962
PACCAR
PCAR
$69.8B
– –
-5,930
Closed -$579K
PDFS icon
963
PDF Solutions
PDFS
$2.02B
– –
-7,224
Closed -$232K
PEG icon
964
Public Service Enterprise Group
PEG
$37.1B
– –
-4,989
Closed -$305K
PHM icon
965
Pultegroup
PHM
$24.6B
– –
-11,910
Closed -$1.23M
PINC
966
DELISTED
Premier
PINC
– –
-14,430
Closed -$323K
POST icon
967
Post Holdings
POST
$3.51B
– –
-13,649
Closed -$1.2M
POWL icon
968
Powell Industries
POWL
$7.54B
– –
-6,939
Closed -$204K
PRTS icon
969
CarParts.com
PRTS
$54.4M
– –
-1,472
Closed -$46.5K
PSA icon
970
Public Storage
PSA
$60.2B
– –
-751
Closed -$229K
PTEN icon
971
Patterson-UTI
PTEN
$4.12B
– –
-15,366
Closed -$166K
PUMP icon
972
ProPetro Holding
PUMP
$1.43B
– –
-13,344
Closed -$112K
QUAD icon
973
Quad
QUAD
$509M
– –
-14,509
Closed -$78.6K
REGN icon
974
Regeneron Pharmaceuticals
REGN
$82B
– –
-714
Closed -$627K
REVG
975
DELISTED
REV Group
REVG
– –
-12,202
Closed -$222K
37 38
39
40 41

Similar funds

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 13.88% 1-Year Est. Return
ISSM
Invesco Senior Secured Management New York $40.9M AUM 3.88% 1-Year Est. Return
KCM
Kawa Capital Management Hallandale Beach, Florida $43.2M AUM 13.52% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
APM
Advanced Portfolio Management New York $32.8M AUM 6.64% 1-Year Est. Return
CI
Centerstone Investors New York $31.8M AUM 32.46% 1-Year Est. Return

Sherbrooke Park Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Sherbrooke Park Advisers held 1,025 positions worth $514M, up 141% from $213M the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

Sherbrooke Park Advisers deployed $293M of net new capital in Q1 2024, opening 585 new positions and adding to 167 existing holdings. Its largest new stake was Amylyx Pharmaceuticals: 299,452 shares worth $850K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Procter & Gamble, an estimated $2.12M trimmed.

  • Sherbrooke Park Advisers's largest Q1 2024 buy was Amylyx Pharmaceuticals: 299,452 shares worth $850K.
  • Sherbrooke Park Advisers added most to SSR Mining in Q1 2024, an estimated $4.08M increase.
  • Sherbrooke Park Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $2.12M.
  • Sherbrooke Park Advisers fully exited Hologic in Q1 2024, selling an estimated $2.01M.
  • Sherbrooke Park Advisers's ten largest holdings make up 5.5% of its $514M portfolio in Q1 2024.
  • Sherbrooke Park Advisers opened 585 new positions and closed 207 in Q1 2024.
  • Sherbrooke Park Advisers's portfolio value rose 141% quarter-over-quarter to $514M.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2024, filed 15 May 2024.